Betaglycan presents ligand to the TGF beta signaling receptor - PubMed (original) (raw)
Betaglycan presents ligand to the TGF beta signaling receptor
F López-Casillas et al. Cell. 1993.
Abstract
Transforming growth factor beta (TGF beta) signals through a heteromeric protein kinase receptor that has a limited ability to bind ligand. This limitation is overcome by the action of betaglycan (TGF beta type III receptor), a separate TGF beta-binding membrane protein of previously unknown function. Betaglycan presents TGF beta directly to the kinase subunit of the signaling receptor, forming a high affinity ternary complex. Membrane betaglycan increases TGF beta binding to the signaling receptor, enhances cell responsiveness to TGF beta, and eliminates marked biological differences between TGF beta isoforms. Thus, betaglycan is a direct regulator of TGF beta access to the signaling receptors.
Similar articles
- Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites.
López-Casillas F, Payne HM, Andres JL, Massagué J. López-Casillas F, et al. J Cell Biol. 1994 Feb;124(4):557-68. doi: 10.1083/jcb.124.4.557. J Cell Biol. 1994. PMID: 8106553 Free PMC article. - Localization of transforming growth factor beta binding site in betaglycan. Comparison with small extracellular matrix proteoglycans.
Fukushima D, Bützow R, Hildebrand A, Ruoslahti E. Fukushima D, et al. J Biol Chem. 1993 Oct 25;268(30):22710-5. J Biol Chem. 1993. PMID: 8226781 - Transforming growth factor-beta blocks inhibin binding to different target cell types in a context-dependent manner through dual mechanisms involving betaglycan.
Farnworth PG, Wang Y, Escalona R, Leembruggen P, Ooi GT, Findlay JK. Farnworth PG, et al. Endocrinology. 2007 Nov;148(11):5355-68. doi: 10.1210/en.2007-0155. Epub 2007 Jul 26. Endocrinology. 2007. PMID: 17656464 - TGF-beta receptors.
Massagué J, Andres J, Attisano L, Cheifetz S, López-Casillas F, Ohtsuki M, Wrana JL. Massagué J, et al. Mol Reprod Dev. 1992 Jun;32(2):99-104. doi: 10.1002/mrd.1080320204. Mol Reprod Dev. 1992. PMID: 1322148 Review. - [TGF beta signalling accessory receptors].
Mokrosiński J, Krajewska WM. Mokrosiński J, et al. Postepy Biochem. 2008;54(3):264-73. Postepy Biochem. 2008. PMID: 19112825 Review. Polish.
Cited by
- Structural Biology and Evolution of the TGF-β Family.
Hinck AP, Mueller TD, Springer TA. Hinck AP, et al. Cold Spring Harb Perspect Biol. 2016 Dec 1;8(12):a022103. doi: 10.1101/cshperspect.a022103. Cold Spring Harb Perspect Biol. 2016. PMID: 27638177 Free PMC article. Review. - Interplay between Cell-Surface Receptors and Extracellular Matrix in Skin.
Kleiser S, Nyström A. Kleiser S, et al. Biomolecules. 2020 Aug 11;10(8):1170. doi: 10.3390/biom10081170. Biomolecules. 2020. PMID: 32796709 Free PMC article. Review. - Transcriptional Profiling of Cultured, Embryonic Epicardial Cells Identifies Novel Genes and Signaling Pathways Regulated by TGFβR3 In Vitro.
DeLaughter DM, Clark CR, Christodoulou DC, Seidman CE, Baldwin HS, Seidman JG, Barnett JV. DeLaughter DM, et al. PLoS One. 2016 Aug 9;11(8):e0159710. doi: 10.1371/journal.pone.0159710. eCollection 2016. PLoS One. 2016. PMID: 27505173 Free PMC article. - Chimeric TβRII-SE/Fc overexpression by a lentiviral vector exerts strong antitumoral activity on colorectal cancer-derived cell lines in vitro and on xenografts.
Romo A, Rodríguez TM, Yu G, Dewey RA. Romo A, et al. Cancer Gene Ther. 2024 Jan;31(1):174-185. doi: 10.1038/s41417-023-00694-z. Epub 2023 Nov 22. Cancer Gene Ther. 2024. PMID: 37993543 - Modulation of noncanonical TGF-β signaling prevents cleft palate in Tgfbr2 mutant mice.
Iwata J, Hacia JG, Suzuki A, Sanchez-Lara PA, Urata M, Chai Y. Iwata J, et al. J Clin Invest. 2012 Mar;122(3):873-85. doi: 10.1172/JCI61498. Epub 2012 Feb 13. J Clin Invest. 2012. PMID: 22326956 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources